pioglitazone
Ligand Summary
Pioglitazone is a thiazolidinedione that depends on the presence of insulin for its mechanism of action. Pioglitazone decreases insulin resistance in the periphery and in the liver resulting in increased insulin-dependent glucose disposal and decreased hepatic glucose output. Pioglitazone is not an insulin secretagogue. Pioglitazone is an agonist for peroxisome proliferator-activated receptor-gamma (PPAR-gamma). PPAR receptors are found in tissues important for insulin action such as adipose tissue, skeletal muscle, and liver. Activation of PPAR-gamma nuclear receptors modulates the transcription of a number of insulin responsive genes involved in the control of glucose and lipid metabolism.
UNII: X4OV71U42S
PubChem: 4829
Guide to Pharmacology: 2694
ChEMBL: CHEMBL595
DrugCentral: 2179
LyCHI: 83H7MQCQ2W8Z
Target Activities
21 Activities
Items per page:
1 – 10 of 21
Activity Type | Activity Value -log(M) | Mechanism of Action | Activity Reference | Publications (PubMed IDs) | ||
---|---|---|---|---|---|---|
- | ||||||
IC50 | ||||||
Ki | ||||||
EC50 | ||||||
Ki | ||||||
EC50 | ||||||
EC50 | ||||||
Ki | ||||||
Ki | ||||||
IC50 | ||||||